Status:
UNKNOWN
Metabolomic Analysis of Body Fluid of Medulloblastoma in Children
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
Pediatric Medulloblastoma
Eligibility:
All Genders
3+ years
Brief Summary
Based on a new mass spectrometry system, body fluid samples were analyzed to verify the role of metabolite analysis in the diagnosis of pediatric medulloblastoma.
Detailed Description
Screening specific molecular metabolic markers for medulloblastoma after radiotherapy can improve the prediction of clinical diagnosis and prognosis of patients.The purpose of this study is to validat...
Eligibility Criteria
Inclusion
- The samples are previous biological sample database data;
- Sample collection time was 2017.05-2019.05;
- The patient's age is over 3 years old;
- KPS score ≥50 at the first diagnosis;
- The patient was a medulloblastoma patient who had received surgical treatment and had not received radiotherapy or chemotherapy before.
Exclusion
- Recurrent patients;
- Patients suffered from other malignant tumors during radiotherapy;
- The body fluid samples or related clinical data are not perfect;
- Storage failure of body fluid samples such as lipid dissolution and hemolysis occurred.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04065204
Start Date
June 1 2019
End Date
June 1 2022
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200092